Press releases
January 19, 2021
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants January 7, 2021
Proteomic data derived from Immunovia’s IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases December 14, 2020
Immunovia publishes link to Webinar No. 3 on IMMray™ PanCan-d: Verification Study and Clinical Use